1. Home
  2. DCTH vs CODI Comparison

DCTH vs CODI Comparison

Compare DCTH & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CODI
  • Stock Information
  • Founded
  • DCTH 1988
  • CODI 2005
  • Country
  • DCTH United States
  • CODI United States
  • Employees
  • DCTH N/A
  • CODI N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CODI Home Furnishings
  • Sector
  • DCTH Health Care
  • CODI Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • CODI Nasdaq
  • Market Cap
  • DCTH 630.4M
  • CODI 565.8M
  • IPO Year
  • DCTH N/A
  • CODI 2006
  • Fundamental
  • Price
  • DCTH $13.85
  • CODI $6.39
  • Analyst Decision
  • DCTH Strong Buy
  • CODI Buy
  • Analyst Count
  • DCTH 4
  • CODI 2
  • Target Price
  • DCTH $24.00
  • CODI $26.00
  • AVG Volume (30 Days)
  • DCTH 531.5K
  • CODI 1.9M
  • Earning Date
  • DCTH 08-04-2025
  • CODI 07-30-2025
  • Dividend Yield
  • DCTH N/A
  • CODI 15.67%
  • EPS Growth
  • DCTH N/A
  • CODI N/A
  • EPS
  • DCTH N/A
  • CODI N/A
  • Revenue
  • DCTH $53,850,000.00
  • CODI $2,198,233,000.00
  • Revenue This Year
  • DCTH $155.42
  • CODI $8.09
  • Revenue Next Year
  • DCTH $37.93
  • CODI $7.62
  • P/E Ratio
  • DCTH N/A
  • CODI N/A
  • Revenue Growth
  • DCTH 1068.87
  • CODI 11.87
  • 52 Week Low
  • DCTH $7.17
  • CODI $6.00
  • 52 Week High
  • DCTH $18.23
  • CODI $24.59
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 37.03
  • CODI 31.99
  • Support Level
  • DCTH $15.72
  • CODI $6.01
  • Resistance Level
  • DCTH $17.35
  • CODI $6.49
  • Average True Range (ATR)
  • DCTH 0.74
  • CODI 0.40
  • MACD
  • DCTH -0.40
  • CODI 0.29
  • Stochastic Oscillator
  • DCTH 2.23
  • CODI 25.16

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: